Literature DB >> 28189850

Low energy costs of F1Fo ATP synthase reversal in colon carcinoma cells deficient in mitochondrial complex IV.

Alexander V Zhdanov1, Dmitry E Andreev2, Pavel V Baranov3, Dmitri B Papkovsky3.   

Abstract

Mitochondrial polarisation is paramount for a variety of cellular functions. Under ischemia, mitochondrial membrane potential (ΔΨm) and proton gradient (ΔpH) are maintained via a reversal of mitochondrial F1Fo ATP synthase (mATPase), which can rapidly deplete ATP and drive cells into energy crisis. We found that under normal conditions in cells with disassembled cytochrome c oxidase complex (COX-deficient HCT116), mATPase maintains ΔΨm at levels only 15-20% lower than in WT cells, and for this utilises relatively little ATP. For a small energy expenditure, mATPase enables mitochondrial ΔpH, protein import, Ca2+ turnover, and supports free radical detoxication machinery enlarged to protect the cells from oxidative damage. Whereas in COX-deficient cells the main source of ATP is glycolysis, the ΔΨm is still maintained upon inhibition of the adenine nucleotide translocators with bongkrekic acid and carboxyatractyloside, indicating that the role of ANTs is redundant, and matrix substrate level phosphorylation alone or in cooperation with ATP-Mg/Pi carriers can continuously support the mATPase activity. Intriguingly, we found that mitochondrial complex III is active, and it contributes not only to free radical production, but also to ΔΨm maintenance and energy budget of COX-deficient cells. Overall, this study demonstrates that F1Fo ATP synthase can support general mitochondrial and cellular functions, working in extremely efficient 'energy saving' reverse mode and flexibly recruiting free radical detoxication and ATP producing / transporting pathways.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioenergetics; Cytochrome c oxidase; F1Fo ATP synthase; Glycolysis; Mitochondria; Reverse mode; SCO2; Substrate level phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28189850     DOI: 10.1016/j.freeradbiomed.2017.02.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  5 in total

1.  Dlg1 Maintains Dendritic Cell Function by Securing Voltage-Gated K+ Channel Integrity.

Authors:  Xuejiao Dong; Lisi Wei; Xueheng Guo; Zhiyong Yang; Chuan Wu; Peiyu Li; Lu Lu; Hai Qi; Yan Shi; Xiaoyu Hu; Li Wu; Liangyi Chen; Wanli Liu
Journal:  J Immunol       Date:  2019-04-26       Impact factor: 5.422

2.  Cytochrome C Oxidase Assembly Factor 1 Homolog Predicts Poor Prognosis and Promotes Cell Proliferation in Colorectal Cancer by Regulating PI3K/AKT Signaling.

Authors:  Yuan Xue; Pei-Dong Li; Xue-Mei Tang; Zai-Hua Yan; Shu-Sen Xia; Hong-Peng Tian; Zuo-Liang Liu; Tong Zhou; Xue-Gui Tang; Guang-Jun Zhang
Journal:  Onco Targets Ther       Date:  2020-11-10       Impact factor: 4.147

3.  Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells.

Authors:  Khalid Kamel; Colm J O'Brien; Alexander V Zhdanov; Dmitri B Papkovsky; Abbot F Clark; W Daniel Stamer; Mustapha Irnaten
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

4.  How to Use Respiratory Chain Inhibitors in Toxicology Studies-Whole-Cell Measurements.

Authors:  Mariusz Żuberek; Patrycja Paciorek; Michał Rakowski; Agnieszka Grzelak
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

5.  Physiologically Relevant Concentrations of Dolutegravir, Emtricitabine, and Efavirenz Induce Distinct Metabolic Alterations in HeLa Epithelial and BV2 Microglial Cells.

Authors:  Joseph W George; Jane E Mattingly; Nashanthea J Roland; Cassandra M Small; Benjamin G Lamberty; Howard S Fox; Kelly L Stauch
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.